« Back
Home /
PRAME 300-309 (HLA-A*02:01)

PRAME 300-309 (HLA-A*02:01)

€115.00

Excl. VAT

Item no.	EP11397_5
Manufacturer	peptides & elephants
Amount	5 mg
Category	Peptides & Proteins Peptides
Type	Peptides
Applications	FC
Specific against	Human (Homo sapiens)
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	ALYVDSLFFL Melanoma antigen preferentially expressed in tumors HLA-A*02:01 Cancer Flow Cytometry
Available
Description	ALYVDSLFFL is a linear peptidic epitope (epitope ID225231) studied as part of Melanoma antigen preferentially expressed in tumors from Homo sapiens (human), tested in T cell assays. Antigen Peptide PRAME 300â€“309 (HLA-A*02:01) ALYVDSLFFL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Keywords	ALYVDSLFFL Melanoma antigen preferentially expressed in tumors HLA-A*02:01 Cancer Flow Cytometry
Sequence	ALYVDSLFFL
N-Terminus	H
C-Terminus	OH
Purity	0, 95
Counter-Ion	TFA
Protein	Melanoma antigen preferentially expressed in tumors
Gene	PRAME
Allele	HLA-A*02:01
Application	Flow Cytometry
Indication	Cancer
Storage	Store dry at -20°C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

Listprice: €115.00

Price: €115.00

available

Delivery expected until 9/18/2025

Quantity:

Compare